Roche Falters In A Key Breast Cancer Readout [Seeking Alpha]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Seeking Alpha
Giredestrant remains on track for approval in other indications, supported by positive evERA and lidERA trial results in breast cancer. While the failed trial may temper peak sales expectations, Roche still anticipates blockbuster potential for giredestrant, targeting over CHF 3 billion by 2030. My Neutral rating reflects that this setback is not existential, but future upside depends on broader execution, especially in obesity and rheumatology. Bulgac/iStock via Getty Images Topline Summary There is a lot you can say about Roche Holding (RHHBY; RHHBF), and their status as a big pharma is many, many disease areas, not just oncology that I would normally find in my wheelhouse. This article will not This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics [Yahoo! Finance]Yahoo! Finance
- Foundation Medicine Launches Whole Genome Sequencing Germline Test for Research Use to Accelerate Biopharmaceutical Research and Therapy Development Beyond Oncology [Yahoo! Finance]Yahoo! Finance
- FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer [Yahoo! Finance]Yahoo! Finance
- Roche's Breast Cancer Drug Falls Short In Phase 3 Study [Yahoo! Finance]Yahoo! Finance
- Foundation Medicine Announces Expanded Participation in National Cancer Institute's ComboMATCH Platform Trials Through Inclusion of Its High-Quality Blood-Based Biomarker Test, FoundationOne®Liquid CDx [Yahoo! Finance]Yahoo! Finance